Cleared Traditional

K893766 - LIFECARE CONT. EPIDURAL CATH. FOR MORPH...

K893766 is an FDA 510(k) clearance for LIFECARE CONT. EPIDURAL CATH. FOR MORPH..., manufactured by Abbott Laboratories. The device is a Class 2 General Hospital device with product code MAJ cleared through the Traditional 510(k) pathway after a 166-day FDA review.

K893766 · Abbott Laboratories · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1989
Decision
166d
Days
Class 2
Risk

K893766 is an FDA 510(k) clearance for the LIFECARE CONT. EPIDURAL CATH. FOR MORPHINE SULFATE. Classified as Catheter, Percutaneous, Intraspinal, Short Term (product code MAJ), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 1, 1989 after a review of 166 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.5120 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K893766

510(k) Number K893766 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 1989
Decision Date November 01, 1989
Days to Decision 166 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 129d · This submission: 166d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MAJ Device Classification - Class 2, Special Controls

Product Code MAJ Catheter, Percutaneous, Intraspinal, Short Term
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.